Bulletin
Investor Alert

Gamida Cell Ltd.

NAS: GMDA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 5, 2022, 6:29 p.m.

/zigman2/quotes/207657083/composite

$

1.90

Change

+0.03 +1.60%

Volume

Volume 1,111

Quotes are delayed by 20 min

/zigman2/quotes/207657083/composite

Today's close

$ 1.76

$ 1.87

Change

+0.11 +6.25%

Day low

Day high

$1.69

$1.91

Open

52 week low

52 week high

$1.47

$4.72

Open

Anat Cohen-Dayag

Currently, Anat Cohen-Dayag occupies the position of President, Chief Executive Officer & Director at Compugen Ltd. She is also on the board of Gamida Cell Ltd., Compugen, Inc., Israel Advanced Technology Industries and Pyxis Diagnostics Ltd.

In her past career she was Head-Research & Development at Mindsense Biosystems Ltd.

She received an undergraduate degree from Ben-Gurion University of the Negev and a doctorate and a graduate degree from Weizmann Institute of Science.

Transactions

Date Shares Transaction Value
01/28/2022 4,000   Award at $0 per share. 0

Officers and Executives

Mr. Robert I. Blum
Chairman
Dr. Julian Adams
Chief Executive Officer & Director
Mr. Michele I. Korfin
Chief Operating & Commercial Officer
Mr. Shai Lankry
Chief Financial Officer
Dr. Yona Geffen
Vice President-Research & Development
Dr. Ronit Simantov
Chief Medical & Scientific Officer
Mr. Vladimir Melnikov
Senior VP-Global Operations & Manufacturing
Mr. Joshua F. Patterson
Chief Compliance Officer & General Counsel
Mr. Tzvi Palash
Chief Manufacturing Officer
Dr. Anat Cohen-Dayag
Director
Dr. Naama Halevi-Davidov
Director
Dr. Ivan M. Borrello
Director
Mr. Yisrael Gewirtz
Internal Auditor
Ms. Heather DiVecchia
Chief of Staff
Dr. Jas Uppal
Chief Regulatory & Quality Officer
Ms. Shawn Cline Tomasello
Independent Director
Mr. Stephen T. Wills
Independent Director
Mr. Kenneth I. Moch
Independent Non-Executive Director
Link to MarketWatch's Slice.